BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 9593923)

  • 1. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
    Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.
    García-Sanz A; Badia A; Clos MV
    Synapse; 2001 Apr; 40(1):65-73. PubMed ID: 11170223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine.
    Ferraro L; Beggiato S; Marcellino D; Frankowska M; Filip M; Agnati LF; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K
    J Neural Transm (Vienna); 2010 May; 117(5):593-7. PubMed ID: 20354886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype.
    Fedele E; Fontana G; Munari C; Cossu M; Raiteri M
    Eur J Neurosci; 1999 Jul; 11(7):2351-8. PubMed ID: 10383624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine modulates allosteric D
    Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
    Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic modulation of K+-evoked [3H]dopamine release in striatal and frontal cortical synaptosomes of normotensive and spontaneous-hypertensive rats.
    Yousfi-Alaoui MA; Hospital S; Garcia-Sanz A; Badia A; Clos MV
    Neurochem Res; 2001 Dec; 26(12):1271-5. PubMed ID: 11885777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG; Sershen H; Lajtha A
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
    Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
    J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
    McGinnis MM; Siciliano CA; Jones SR
    J Neurochem; 2016 Sep; 138(6):821-9. PubMed ID: 27393374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
    Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
    J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
    Zapata A; Shippenberg TS
    Neuropharmacology; 2005 Jan; 48(1):43-50. PubMed ID: 15617726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.
    Koeltzow TE; Xu M; Cooper DC; Hu XT; Tonegawa S; Wolf ME; White FJ
    J Neurosci; 1998 Mar; 18(6):2231-8. PubMed ID: 9482807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.
    Rouge-Pont F; Usiello A; Benoit-Marand M; Gonon F; Piazza PV; Borrelli E
    J Neurosci; 2002 Apr; 22(8):3293-301. PubMed ID: 11943831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.
    Centonze D; Picconi B; Baunez C; Borrelli E; Pisani A; Bernardi G; Calabresi P
    Neuropsychopharmacology; 2002 Feb; 26(2):164-75. PubMed ID: 11790512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices.
    Kaiser SA; Soliakov L; Harvey SC; Luetje CW; Wonnacott S
    J Neurochem; 1998 Mar; 70(3):1069-76. PubMed ID: 9489727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.